Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Matteo Ponzano, Matheus J. Wiest, André Coleman, Emily Newton, Maureen Pakosh, Eleni M. Patsakos, David S. K. Magnuson, Lora M. Giangregorio & B. Catharine Craven. (2023) The use of alkaline phosphatase as a bone turnover marker after spinal cord injury: A scoping review of human and animal studies. The Journal of Spinal Cord Medicine 46:2, pages 167-180.
Read now
Read now
Yongfeng Zhang, Xin Liu, Yangyang Li, Minkai Song, Yutong Li, Anhui Yang, Yaqin Zhang, Di Wang & Min Hu. (2021) Aucubin slows the development of osteoporosis by inhibiting osteoclast differentiation via the nuclear factor erythroid 2-related factor 2-mediated antioxidation pathway. Pharmaceutical Biology 59:1, pages 1554-1563.
Read now
Read now
Satoshi Soen, Saeko Fujiwara, Ryoichi Takayanagi, Kenta Kajimoto, Mika Tsujimoto, Shuichi Kimura, Masayo Sato, John H. Krege & Hiroyuki Enomoto. (2017) Real-world effectiveness of daily teriparatide in Japanese patients with osteoporosis at high risk for fracture: final results from the 24-month Japan Fracture Observational Study (JFOS). Current Medical Research and Opinion 33:11, pages 2049-2056.
Read now
Read now
Atsushi Nishikawa, Fumito Yoshiki, Masanori Taketsuna, Kenta Kajimoto & Hiroyuki Enomoto. (2016) Safety and effectiveness of daily teriparatide for osteoporosis in patients with severe stages of chronic kidney disease: post hoc analysis of a postmarketing observational study. Clinical Interventions in Aging 11, pages 1653-1659.
Read now
Read now
Articles from other publishers (18)
Weifei Zhang, Yuheng Liu, Yuanrui Luo, Xiang Shu, Congmin Pu, Bin Zhang, Pin Feng, Ao Xiong & Qingquan Kong. (2023) New insights into the role of long non-coding RNAs in osteoporosis. European Journal of Pharmacology 950, pages 175753.
Crossref
Crossref
Qin Xu, Dan Li, Jing Chen, Ju Yang, Jiai Yan, Yanping Xia, Feng Zhang, Xuesong Wang & Hong Cao. (2022) Crosstalk between the gut microbiota and postmenopausal osteoporosis: Mechanisms and applications. International Immunopharmacology 110, pages 108998.
Crossref
Crossref
Bo Li, Yu Wang, Shiqiang Gong, Weifan Yao, Hua Gao, Mingyan Liu & Minjie Wei. (2022) Puerarin improves OVX-induced osteoporosis by regulating phospholipid metabolism and biosynthesis of unsaturated fatty acids based on serum metabolomics. Phytomedicine 102, pages 154198.
Crossref
Crossref
Nandipati Venkata Sandeep, Aneez Joseph, Kripa Elizabeth Cherian, Nitin Kapoor & Thomas V Paul. (2022) Impact of teriparatide therapy in Indian postmenopausal women with osteoporosis with regard to DXA-derived parameters. Therapeutic Advances in Endocrinology and Metabolism 13, pages 204201882211129.
Crossref
Crossref
Yevgeniya Kushchayeva & E. Michael Lewiecki. 2021. Image Guided Interventions of the Spine. Image Guided Interventions of the Spine
61
92
.
Caitlin Prather, Erin Adams & Whitney Zentgraf. (2020) Romosozumab: A first-in-class sclerostin inhibitor for osteoporosis. American Journal of Health-System Pharmacy 77:23, pages 1949-1956.
Crossref
Crossref
Kota Morishita, Shin-ichi Yamada, Akiko Kawakita, Masao Hashidume, Akira Tachibana, Noritami Takeuchi, Yumiko Ohbayashi, Takahiro Kanno, Daigo Yoshiga, Takashi Narai, Noboru Sasaki, Hisayuki Shinohara, Narikazu Uzawa, Minoru Miyake, Kazuhiro Tominaga, Isamu Kodani, Masahiro Umeda & Hiroshi Kurita. (2020) Treatment outcomes of adjunctive teriparatide therapy for medication-related osteonecrosis of the jaw (MRONJ): A multicenter retrospective analysis in Japan. Journal of Orthopaedic Science 25:6, pages 1079-1083.
Crossref
Crossref
N. R. Fuggle, C. Cooper, N. C. Harvey, N. Al-Daghri, M.-L. Brandi, O. Bruyere, A. Cano, E. M. Dennison, A. Diez-Perez, J.-M. Kaufman, S. Palacios, D. Prieto-Alhambra, S. Rozenberg, T. Thomas, F. Tremollieres, R. Rizzoli, J. A. Kanis & J. Y. Reginster. (2020) Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs. Drugs 80:15, pages 1537-1552.
Crossref
Crossref
Chia-Yu Hsu, Li-Ru Chen & Kuo-Hu Chen. (2020) Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review. International Journal of Molecular Sciences 21:18, pages 6846.
Crossref
Crossref
Abdul Aziz Elsalmawy, Nadia S. Al-Ali, Yasser Yaghi, Hussein Assaggaf, Ghassan Maalouf, Mir Sadat-Ali, Essam Zaher, Said Saghieh, Ahmed Mahmoud & Mohamed Taher. (2020) Middle East experience from the Asia And Latin America Fracture Observational Study (ALAFOS): Baseline characteristics of postmenopausal women with osteoporosis using teriparatide. Journal of International Medical Research 48:8, pages 030006052094085.
Crossref
Crossref
Sho Kato, Hiroki Wakabayashi, Taro Nakagawa, Gaku Miyamura, Yohei Naito, Takahiro Iino & Akihiro Sudo. (2019) Teriparatide improves pain-related behavior and prevents bone loss in ovariectomized mice. Journal of Orthopaedic Surgery 28:1, pages 230949901989319.
Crossref
Crossref
Tetsuya Ogawa, Shusa Ohshika, Michiro Yanagisawa, Akira Kurose & Yasuyuki Ishibashi. (2019) Teriparatide may accelerate the growth of a pre‑existing malignant tumor in an elderly patient with osteoporosis: A case report. Molecular and Clinical Oncology.
Crossref
Crossref
Eloi Franco-Trepat, María Guillán-Fresco, Ana Alonso-Pérez, Alberto Jorge-Mora, Vera Francisco, Oreste Gualillo & Rodolfo Gómez. (2019) Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis. Journal of Clinical Medicine 8:8, pages 1178.
Crossref
Crossref
Emiko Ifuku, Takeshi Yoshimura, Toyonobu Uzawa & Tadami Hokonohara. (2019) Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk. Osteoporosis and Sarcopenia 5:2, pages 44-50.
Crossref
Crossref
Anne-Luise Thorsteinsson, Louise Hansen, Peter Vestergaard & Pia Eiken. (2018) Long-term benefits and risks of parathyroid hormone treatment in compliant osteoporotic patients. A Danish national register based cohort study. Archives of Osteoporosis 13:1.
Crossref
Crossref
Arjun S. Sebastian & Jeffrey A. Rihn. (2018) Vertebral fracture management. Seminars in Spine Surgery 30:1, pages 17-23.
Crossref
Crossref
Li Xiaofeng, Xu Daxia & Chen Yunzhen. (2017) Teriparatide as a nonoperative treatment for tibial and femoral fracture nonunion. Medicine 96:16, pages e6571.
Crossref
Crossref
Fumito Yoshiki, Atsushi Nishikawa, Masanori Taketsuna, Kenta Kajimoto & Hiroyuki Enomoto. (2017) Efficacy and safety of teriparatide in bisphosphonate-pretreated and treatment-naive patients with osteoporosis at high risk of fracture: Post hoc analysis of a prospective observational study. Journal of Orthopaedic Science 22:2, pages 330-338.
Crossref
Crossref